• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性因素不孕症诊断与治疗的当前弊端及未来展望,重点关注促卵泡生成素治疗:专家意见

Current drawbacks and future perspectives in the diagnosis and treatment of male factor infertility, with a focus on FSH treatment: an expert opinion.

作者信息

Santi D, Corona G, Salonia A, Ferlin A

机构信息

Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Endocrinology Unit, Azienda AUSL, Bologna, Italy.

出版信息

J Endocrinol Invest. 2025 May;48(5):1085-1100. doi: 10.1007/s40618-024-02524-x. Epub 2025 Jan 13.

DOI:10.1007/s40618-024-02524-x
PMID:39804439
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12049307/
Abstract

PURPOSE

Infertility is defined as the inability to conceive after 1 year of unprotected intercourse, affecting approximately 15-20% of couples in Western countries. It is a shared problem within the couple; when the main issue lies with one of the partners, it is preferable to refer to "male factor" or "female factor" infertility rather than simply male or female infertility. Despite male factor infertility accounting for half of all couple infertility cases, the clinical approach to the male partner is not uniformly standardized across international guidelines.

METHODS

To provide an expert overview, we have comprehensively reviewed and critically analyzed the most up-to-date literature on this sensitive topic, leading to the development of a proposal for tailored assessment of the diagnostic-therapeutic pathway and preventive strategies. The diagnostic approach also considers that infertile men are objectively less healthy than their fertile counterparts of the same age and ethnicity.

RESULTS

This article discusses the diagnostic flow, the classification of male factor infertility, the definition of idiopathic infertility, the involvement of general health, and treatment recommendations, emphasizing follicle-stimulating hormone treatment in selected groups of patients.

CONCLUSION

We provide expert opinion on current drawbacks and future perspectives in this field, with practical advice for the clinical practice of general practitioners and expert in reproductive medicine.

摘要

目的

不孕症被定义为在无保护性交1年后仍无法受孕,在西方国家约15%-20%的夫妇受其影响。这是夫妻双方共同面临的问题;当主要问题出在一方时,最好称其为“男性因素”或“女性因素”不孕症,而非简单的男性或女性不孕症。尽管男性因素不孕症占所有夫妻不孕症病例的一半,但国际指南中针对男性伴侣的临床治疗方法并不统一规范。

方法

为提供专家综述,我们全面回顾并批判性分析了关于这一敏感话题的最新文献,进而制定了一份针对诊断-治疗路径及预防策略的个性化评估建议。诊断方法还考虑到,客观上不育男性的健康状况不如同年龄、同种族的可育男性。

结果

本文讨论了诊断流程、男性因素不孕症的分类、特发性不孕症的定义、总体健康状况的影响以及治疗建议,重点强调了特定患者群体的促卵泡激素治疗。

结论

我们针对该领域当前的不足和未来前景提供专家意见,并为全科医生和生殖医学专家的临床实践提供实用建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/745d/12049307/05c642cf8237/40618_2024_2524_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/745d/12049307/05c642cf8237/40618_2024_2524_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/745d/12049307/05c642cf8237/40618_2024_2524_Fig1_HTML.jpg

相似文献

1
Current drawbacks and future perspectives in the diagnosis and treatment of male factor infertility, with a focus on FSH treatment: an expert opinion.男性因素不孕症诊断与治疗的当前弊端及未来展望,重点关注促卵泡生成素治疗:专家意见
J Endocrinol Invest. 2025 May;48(5):1085-1100. doi: 10.1007/s40618-024-02524-x. Epub 2025 Jan 13.
2
Practical Clinical and Diagnostic Pathway for the Investigation of the Infertile Couple.实用的临床和诊断途径,以调查不孕夫妇。
Front Endocrinol (Lausanne). 2021 Jan 19;11:591837. doi: 10.3389/fendo.2020.591837. eCollection 2020.
3
FSHB -211G>T stratification for follicle-stimulating hormone treatment of male infertility patients: making the case for a pharmacogenetic approach in genetic functional secondary hypogonadism.促卵泡激素β亚基基因(FSHB)-211G>T分层在男性不育患者促卵泡激素治疗中的应用:为遗传性功能性继发性性腺功能减退的药物遗传学方法提供依据
Andrology. 2015 Nov;3(6):1050-3. doi: 10.1111/andr.12094. Epub 2015 Oct 7.
4
Use of follicle-stimulating hormone for the male partner of idiopathic infertile couples in Italy: Results from a multicentre, observational, clinical practice survey.意大利特发性不孕夫妇中男性使用促卵泡激素的情况:一项多中心、观察性、临床实践调查的结果。
Andrology. 2020 May;8(3):637-644. doi: 10.1111/andr.12748. Epub 2020 Jan 7.
5
Gonadotropins in the Management of Couple Infertility: Toward the Rational Use of an Empirical Therapy.促性腺激素在治疗夫妇不孕中的应用:迈向经验性治疗的合理应用。
Semin Reprod Med. 2023 Nov;41(6):258-266. doi: 10.1055/s-0043-1777837. Epub 2023 Dec 29.
6
[The diagnostic of male infertility - an important part of reproductive medicine].[男性不育的诊断——生殖医学的重要组成部分]
Ther Umsch. 2009 Dec;66(12):789-95. doi: 10.1024/0040-5930.66.12.789.
7
FSH treatment of male idiopathic infertility: Time for a paradigm change.FSH 治疗男性特发性不育症:范式转变的时机。
Andrology. 2020 May;8(3):535-544. doi: 10.1111/andr.12746. Epub 2020 Jan 8.
8
Infertile couples still undergo assisted reproductive treatments without initial andrological evaluation in the real-life setting: A failure to adhere to guidelines?在实际情况下,不孕夫妇在没有初始男科评估的情况下仍然接受辅助生殖治疗:这是不遵守指南的表现吗?
Andrology. 2021 Nov;9(6):1843-1852. doi: 10.1111/andr.13071. Epub 2021 Sep 22.
9
In vitro fertilization and multiple pregnancies: an evidence-based analysis.体外受精与多胎妊娠:一项基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(18):1-63. Epub 2006 Oct 1.
10
FSH for the Treatment of Male Infertility.促卵泡激素治疗男性不育。
Int J Mol Sci. 2020 Mar 25;21(7):2270. doi: 10.3390/ijms21072270.

本文引用的文献

1
Human Infertility and Reproductive Endocrinology.人类不育与生殖内分泌学
Life (Basel). 2024 Nov 26;14(12):1550. doi: 10.3390/life14121550.
2
Short-Term Hormonal Changes Following Microdissection Testicular Sperm Extraction among Men with Non-Obstructive Azoospermia: Findings from a Large Longitudinal Prospective Multicentric Study.非梗阻性无精子症男性显微取精术后的短期激素变化:一项大型纵向前瞻性多中心研究的结果
World J Mens Health. 2024 Nov 27. doi: 10.5534/wjmh.240184.
3
The Andrological Landscape in the Twenty-First Century: Making Sense of the Advances in Male Infertility Management for the Busy Clinicians.
二十一世纪的男科领域:为忙碌的临床医生梳理男性不育症管理的进展。
Int J Environ Res Public Health. 2024 Sep 17;21(9):1222. doi: 10.3390/ijerph21091222.
4
Male Fertility as a Proxy for Health.男性生育能力作为健康的一个指标。
J Clin Med. 2024 Sep 19;13(18):5559. doi: 10.3390/jcm13185559.
5
Recommendations from the 2024 Australian evidence-based guideline for unexplained infertility: ADAPTE process from the ESHRE evidence-based guideline on unexplained infertility.2024 年澳大利亚不明原因不孕循证指南推荐意见:ESHRE 不明原因不孕循证指南 ADAPTE 过程。
Med J Aust. 2024 Oct 21;221(8):438-446. doi: 10.5694/mja2.52437. Epub 2024 Sep 15.
6
FSH Therapy in Male Factor Infertility: Evidence and Factors Which Might Predict the Response.男性因素不育中的促卵泡生成素治疗:证据及可能预测反应的因素
Life (Basel). 2024 Jul 31;14(8):969. doi: 10.3390/life14080969.
7
Epididymal Cyst Lesions Are Not Associated With Impaired Semen Parameters Among Men Presenting for Fertility Evaluation.附睾囊肿病变与前来进行生育力评估的男性的精液参数受损无关。
J Urol. 2024 Dec;212(6):891-898. doi: 10.1097/JU.0000000000004224. Epub 2024 Aug 26.
8
Updates to Male Infertility: AUA/ASRM Guideline (2024).男性不育症更新:AUA/ASRM 指南(2024 年)。
J Urol. 2024 Dec;212(6):789-799. doi: 10.1097/JU.0000000000004180. Epub 2024 Aug 15.
9
Contemporary Diagnostic Work-Up for Male Infertility: Emphasizing Comprehensive Baseline Assessment.男性不育症的当代诊断检查:强调全面的基线评估。
World J Mens Health. 2025 Apr;43(2):265-281. doi: 10.5534/wjmh.240069. Epub 2024 Jun 19.
10
Mother, father, son and the Italian Law 40/2004. No 'delete' key.母亲、父亲、儿子与意大利第 40/2004 号法律:没有“删除”键。
Reprod Biomed Online. 2024 Jul;49(1):103970. doi: 10.1016/j.rbmo.2024.103970. Epub 2024 Mar 21.